Samsun Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.51 M
as on 27-12-2024
- Paid Up Capital ₹ 0.51 M
as on 27-12-2024
- Company Age 14 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.43 Cr
as on 27-12-2024
- Satisfied Charges ₹ 5.55 Cr
as on 27-12-2024
- Revenue 34.79%
(FY 2022)
- Profit 615.96%
(FY 2022)
- Ebitda 33.51%
(FY 2022)
- Net Worth 9.23%
(FY 2022)
- Total Assets -2.38%
(FY 2022)
About Samsun Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.51 M and a paid-up capital of Rs 0.51 M.
The company currently has active open charges totaling ₹2.43 Cr. The company has closed loans amounting to ₹5.55 Cr, as per Ministry of Corporate Affairs (MCA) records.
Karnail Thandi, Sanjay Tripathi, Shashi Patel, and One other member serve as directors at the Company.
- CIN/LLPIN
U74900UP2010PTC042215
- Company No.
042215
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Oct 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Unnao, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Samsun Biotech Private Limited offer?
Samsun Biotech Private Limited offers a wide range of products and services, including Animal Feed Supplement, Poultry Feed Supplements, Bird Food, Poultry & Animal Food, Animal Medicines & Health Care, Veterinary Medicines, Cattle Feed Supplement.
Who are the key members and board of directors at Samsun Biotech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Karnail Thandi  | Director | 08-Oct-2010 | Current |
| Sanjay Tripathi | Director | 08-Oct-2010 | Current |
| Shashi Patel | Director | 08-Oct-2010 | Current |
| Vijay Tripathi | Director | 08-Oct-2010 | Current |
Financial Performance of Samsun Biotech.
Samsun Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 34.79% increase. The company also saw a substantial improvement in profitability, with a 615.96% increase in profit. The company's net worth moved up by a moderate rise of 9.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Samsun Biotech?
In 2022, Samsun Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Oct 2023 | ₹1.58 Cr | Open |
Axis Bank Limited Creation Date: 21 Jul 2020 | ₹2.50 M | Open |
Axis Bank Limited Creation Date: 22 Mar 2018 | ₹6.00 M | Open |
How Many Employees Work at Samsun Biotech?
Samsun Biotech has a workforce of 17 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Samsun Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Samsun Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
